Dr. Hamilton Discusses Trastuzumab deruxtecan - NBCLX
Автор: Sarah Cannon Research Institute
Загружено: 2021-10-04
Просмотров: 4679
Sarah Cannon breast cancer and gynecologic cancer expert, Dr. Erika Hamilton joined NBLX to discuss Trastuzumab deruxtecan, which is part of a new class of medicines working to use targeted chemotherapy to only attack the cancer cell. It is improving outcomes for HER-2 positive cancers which represent about 15% of breast cancers in the U.S.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: